Ron Rowland

About the Author Ron Rowland

Ron Rowland has been providing market commentary and active investment advice since 1991. He is the founder and editor of Invest With An Edge, a website and weekly newsletter providing free actionable ideas for ETFs, stocks, and mutual funds. Additionally, he is the Executive Editor and Publisher of the All Star Fund Trader newsletter (http://allstarinvestor.com), a highly regarded paid subscription investment service he started in 1991. Ron is also president and founder of Capital Cities Asset Management, a registered investment advisor providing separate account management and investment research for individual investors as well as other advisors and institutions. Outside of CCAM, Ron serves on the Board of Directors for the National Association of Active Investment Managers (NAAIM) and is chairperson of the Active Fund Index committee.

ETF Deathwatch For December 2014: A Zombie Milestone


The ETF Deathwatch membership roll contains four fewer products this month. Ten new names joined the list, and fourteen came off. Ten of the removals were due to improved health, while the other four ceased operations in November. The overall count now stands at 327, consisting of 226 ETFs and 101 ETNs.

Zombie ETFs achieved a major milestone in November. The iPath Short Enhanced MSCI Emerging Markets Index ETN (NYSEARCA:EMSA), long the poster child of ETF Deathwatch, has now gone more than two years without a single trade. Barclays launched the EMSA ETN in November 2010 and wascriticized for its inability to describe the product’s use of leverage. EMSA then proceeded to join ETF Deathwatch in June 2011, the first month it became eligible.

Trading in EMSA was sporadic at best. As the calendar rolled over to 2012, activity dwindled further. It saw zero volume on about half the days in January, then it dried up completely for all of February and March. Transactions took place on only one day in April, two days in May, and two days in June. That was it until November 9, 2012 when EMSA recorded its last trade – 100 shares at $81.61.

Now, more than two years later, we are still awaiting its next trade. The quote screen is very telling. I’m currently looking at a bid price of $40.44 and an ask of $121.30, for a spread of $80.86. According to the iPath website, EMSA has a current value of $77.91 and about $4.4 million in assets. I fail to comprehend why a product like this is allowed to remain listed. So, why is it still listed? Possibly because the 3.30% expense ratio means that Barclays takes in about $145,000 per year on a dead product.

EMSA is possibly the most egregious example of a zombie ETP, but it is not alone. There were 13 ETPs that went the entire month of November without a trade. On the last day of the month, 265 products posted zero volume. Nearly 16% of all listed ETPs did not trade that day. The true danger of owning products on this list is not knowing if any buyers will show up when you want to sell your shares.

One of the oldest ETFs on Deathwatch escaped this month. BLDRS Europe 100 ADR Index ETF (NASDAQ:ADRU) is more than 144 months (12 years) old and had enough increase in trading activity the past three months to finally come off. However, the average age of products on the list still increased from 46.2 to 46.6 months, and 95 are now more than five years in age. The average asset size is $6.6 million, up from $6.5 million a month ago, and 59 have asset levels of less than $2 million.

Here is the Complete List of 327 Products on ETF Deathwatch for December 2014 compiled using the objective ETF Deathwatch Criteria.

The 10 ETPs added to ETF Deathwatch for December:

  1. Claymore CEF Index GS Connect ETN (NYSEARCA:GCE)
  2. Deutsche X-trackers Solactive Investment Grade Subordinated Debt (NYSEARCA:SUBD)
  3. Direxion Daily 20+ Year Treasury Bear 1x (NYSEARCA:TYBS)
  4. First Trust Managed Municipal (NASDAQ:FMB)
  5. IQ Canada Small Cap (NYSEARCA:CNDA)
  6. iShares iBonds Dec 2016 Corporate Term (NYSEARCA:IBDF)
  7. iShares iBonds Dec 2018 Corporate Term (NYSEARCA:IBDH)
  8. iShares MSCI Emerging Markets Value (NASDAQ:EVAL)
  9. WisdomTree Commodity Currency Strategy (NYSEARCA:CCX)
  10. WisdomTree Europe Dividend Growth (NYSEARCA:EUDG)

The 10 ETPs removed from ETF Deathwatch due to improved health:

  1. BLDRS Europe 100 ADR (ADRU)
  2. EGShares India Consumer (NYSEARCA:INCO)
  3. ETRACS CMCI Silver TR ETN (NYSEARCA:USV)
  4. iPath Pure Beta Cocoa ETN (NYSEARCA:CHOC)
  5. PowerShares DB 3x Long USD Index Futures ETN (NYSEARCA:UUPT)
  6. ProShares Ultra MSCI Brazil Capped (NYSEARCA:UBR)
  7. ProShares UltraShort MSCI EAFE (NYSEARCA:EFU)
  8. SPDR Russell 1000 Low Volatility (NYSEARCA:LGLV)
  9. VelocityShares 3x Long Crude ETN (NYSEARCA:UWTI)
  10. WisdomTree BofA ML High Yield Bond Negative Duration (NASDAQ:HYND)

The 4 ETPs removed from ETF Deathwatch due to delisting:

  1. VelocityShares Emerging Asia DR ETF (NASDAQ:ASDR)
  2. VelocityShares Emerging Markets DR ETF (NASDAQ:EMDR)
  3. VelocityShares Russia DR ETF (NASDAQ:RUDR)
  4. Barclays ETN+ S&P 500 3x Long B ETN (NYSEARCA:BXUB)

According to TipRanks.com, which measures analysts’ and bloggers’ success rate based on how their calls perform, blogger Ron Rowland has a total average return of +20.2% and a 67% success rate. Ron Rowland is Ranked #1862 out of 4041 Bloggers

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts